Abbvie Inc.

Basf Se Corporation

Merck Patent Gmbh

Thomas Mueller

Dieter Dorsch

Yi Gao

Margarita Wucherer-Plietker

Eugen Merkul

Klaus Hauser

Ping Tong

Nancy E Sever

Ulrich Westedt

Ute Lander

Harald Hach

Adivaraha Jayasankar

Regina Reul

Donghua Zhu

Marius Naris

Constanze Obermiller

Colleen Garrett

Michael Simon

Katrin Schneider

Samuel Kyeremateng

Benedikt Steitz

Katharina Asmus

Michael Siimon

Roland Schwab

Michael Brandner

Bernd Ziegler

Fred Vogelsgesang

Felix Arndt Volkmann

Florian Bechtold

Trung Hieu Ngo

Sebastian Mathias Schillo

The present invention features solid pharmaceutical compositions comprising Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes (1) a first layer which comprises 100 mg Compound 1, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion; and (2) a second layer which comprises 40 mg Compound 2, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion.

Solid pharmaceutical compositions for treating HCV

Growing community of inventors

Ludwigshafen, Germany

Thomas Mueller